<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Hipertensión arterial &#187; Ensayo clinico</title>
	<atom:link href="https://files.sld.cu/hta/archives/category/ensayo-clinico/feed" rel="self" type="application/rss+xml" />
	<link>https://files.sld.cu/hta</link>
	<description>Hipertensión arterial</description>
	<lastBuildDate>Wed, 09 May 2018 21:30:19 +0000</lastBuildDate>
	<language>es-ES</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=4.1</generator>
	<item>
		<title>Revisión de los principales estudios sobre los beneficios del tratamiento de la hipertensión arterial  (1998-2002)</title>
		<link>https://files.sld.cu/hta/archives/445</link>
		<comments>https://files.sld.cu/hta/archives/445#comments</comments>
		<pubDate>Tue, 16 Feb 2010 17:41:58 +0000</pubDate>
		<dc:creator><![CDATA[Jorge Luis León Alvarez]]></dc:creator>
				<category><![CDATA[Ensayo clinico]]></category>
		<category><![CDATA[Revisón de estudios]]></category>

		<guid isPermaLink="false">http://files.sld.cu/hta/?p=445</guid>
		<description><![CDATA[Sociedad Española de Medicina Familiar revision-de-los-principales-estudios-sobre-tratamiento-de-la-hta-1998-2002]]></description>
				<content:encoded><![CDATA[<p>Sociedad Española de Medicina Familiar  <a href='http://files.sld.cu/hta/files/2010/02/revision-de-los-principales-estudios-sobre-tratamiento-de-la-hta-1998-2002.pdf'>revision-de-los-principales-estudios-sobre-tratamiento-de-la-hta-1998-2002</a></p>
]]></content:encoded>
			<wfw:commentRss>https://files.sld.cu/hta/archives/445/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial.</title>
		<link>https://files.sld.cu/hta/archives/372</link>
		<comments>https://files.sld.cu/hta/archives/372#comments</comments>
		<pubDate>Mon, 04 Jan 2010 14:12:22 +0000</pubDate>
		<dc:creator><![CDATA[Jorge Luis León Alvarez]]></dc:creator>
				<category><![CDATA[Ensayo clinico]]></category>
		<category><![CDATA[ensayo clinico de nuevo medicamento]]></category>

		<guid isPermaLink="false">http://files.sld.cu/hta/?p=372</guid>
		<description><![CDATA[lancet-2009-a-selective-endothelin-eceptor-antagonist-to-reduce-blood-pressure-in-patients-with-treatment-resistant-hypertension-a-randomised-double-blind-placebo-controlled-trialPor: Michael A Weber, Henry Black, George Bakris, Henry Krum, Stuart Linas, Robert Weiss, Jennifer V Linseman, Brian L Wiens, Marshelle S Warren y Lars H Lindholm. www.thelancet.com Published online September 14, 2009.]]></description>
				<content:encoded><![CDATA[<p><a href="http://files.sld.cu/hta/files/2010/01/lancet-2009-a-selective-endothelin-eceptor-antagonist-to-reduce-blood-pressure-in-patients-with-treatment-resistant-hypertension-a-randomised-double-blind-placebo-controlled-trial.pdf">lancet-2009-a-selective-endothelin-eceptor-antagonist-to-reduce-blood-pressure-in-patients-with-treatment-resistant-hypertension-a-randomised-double-blind-placebo-controlled-trial</a>Por: Michael A Weber, Henry Black, George Bakris, Henry Krum, Stuart Linas, Robert Weiss, Jennifer V Linseman, Brian L Wiens, Marshelle S Warren y Lars H Lindholm. www.thelancet.com Published online September 14, 2009.</p>
]]></content:encoded>
			<wfw:commentRss>https://files.sld.cu/hta/archives/372/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
